These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8833891)

  • 21. Etiologies of the urinary tract infections in a Yemeni City.
    Nasher MA; Nasher TM; Gunaid AA
    Saudi Med J; 2001 Jul; 22(7):599-602. PubMed ID: 11479641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.
    Mendes RE; Castanheira M; Woosley LN; Stone GG; Bradford PA; Flamm RK
    Int J Antimicrob Agents; 2018 Aug; 52(2):287-292. PubMed ID: 29654893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
    Ishikawa K; Hamasuna R; Uehara S; Yasuda M; Yamamoto S; Hayami H; Takahashi S; Matsumoto T; Minamitani S; Kadota J; Iwata S; Kaku M; Watanabe A; Sunakawa K; Sato J; Hanaki H; Tsukamoto T; Kiyota H; Egawa S; Deguchi T; Matsumoto M; Tanaka K; Arakawa S; Fujisawa M; Kumon H; Kobayashi K; Matsubara A; Wakeda H; Amemoto Y; Onodera S; Goto H; Komeda H; Yamashita M; Takenaka T; Fujimoto Y; Tsugawa M; Takahashi Y; Maeda H; Onishi H; Ishitoya S; Nishimura K; Mitsumori K; Ito T; Togo Y; Nakamura I; Ito N; Kanamaru S; Hirose T; Muranaka T; Yamada D; Ishihara S; Oka H; Inatomi H; Matsui T; Kobuke M; Kunishima Y; Kimura T; Ichikawa T; Kagara I; Matsukawa M; Takahashi K; Mita K; Kato M; Okumura K; Kawanishi H; Hashimura T; Aoyama T; Shigeta M; Koda S; Taguchi K; Matsuda Y
    J Infect Chemother; 2015 Sep; 21(9):623-33. PubMed ID: 26166322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection.
    Armbruster CE; Smith SN; Johnson AO; DeOrnellas V; Eaton KA; Yep A; Mody L; Wu W; Mobley HLT
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary Concentrations and Antibacterial Activity of BAL30072, a Novel Siderophore Monosulfactam, against Uropathogens after Intravenous Administration in Healthy Subjects.
    Straubinger M; Blenk H; Naber KG; Wagenlehner FM
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3309-15. PubMed ID: 26976871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of asymptomatic bacteriuria in Egyptian school-going children.
    Mohammed A; Abdelfattah M; Ibraheem A; Younes A
    Afr Health Sci; 2016 Mar; 16(1):69-74. PubMed ID: 27358615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competitive accumulation of betaines by Escherichia coli K-12 and derivative strains lacking betaine porters.
    Randall K; Lever M; Peddie BA; Chambers ST
    Biochim Biophys Acta; 1995 Aug; 1245(1):116-20. PubMed ID: 7654759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesion of Escherichia coli in urinary tract infection.
    Edén CS; Hagberg L; Hanson LA; Korhonen T; Leffler H; Olling S
    Ciba Found Symp; 1981; 80():161-87. PubMed ID: 6114819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli.
    O'Hanley P; Low D; Romero I; Lark D; Vosti K; Falkow S; Schoolnik G
    N Engl J Med; 1985 Aug; 313(7):414-20. PubMed ID: 2862582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infections: correlation between organisms obtained simultaneously from the urine and feces of patients with bacteriuria and pyuria.
    Schwarz H; Schirmer HK; Ehlers B; Post B
    J Urol; 1969 May; 101(5):765-7. PubMed ID: 4976354
    [No Abstract]   [Full Text] [Related]  

  • 33. Osmoprotective activity, urea protection, and accumulation of hydrophilic betaines in Escherichia coli and Staphylococcus aureus.
    Peddie BA; Lever M; Randall K; Chambers ST
    Antonie Van Leeuwenhoek; 1999 Apr; 75(3):183-9. PubMed ID: 10427406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that Escherichia coli accumulates glycine betaine from marine sediments.
    Ghoul M; Bernard T; Cormier M
    Appl Environ Microbiol; 1990 Feb; 56(2):551-4. PubMed ID: 2407188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pattern of antimicrobial susceptibility in uropathogen isolates from children].
    Suárez VM; Suárez RC; Pérez BA; Alvarez FA; Castro SP; Rodríguez FS; Guerrero SM
    Rev Esp Quimioter; 2001 Mar; 14(1):63-8. PubMed ID: 11376352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract.
    Johanson IM; Plos K; Marklund BI; Svanborg C
    Microb Pathog; 1993 Aug; 15(2):121-9. PubMed ID: 7902954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometry analysis using sysmex UF-1000i classifies uropathogens based on bacterial, leukocyte, and erythrocyte counts in urine specimens among patients with urinary tract infections.
    Monsen T; Rydén P
    J Clin Microbiol; 2015 Feb; 53(2):539-45. PubMed ID: 25472486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
    Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
    Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for feedback (trans) regulation of, and two systems for, glycine betaine transport by Staphylococcus aureus.
    Stimeling KW; Graham JE; Kaenjak A; Wilkinson BJ
    Microbiology (Reading); 1994 Nov; 140 ( Pt 11)():3139-44. PubMed ID: 7812453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.